Lin BioScience Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33,255	32,842	10,812	8,946	12,583	12,832
Market Cap Growth	248.27%	203.77%	20.85%	-28.90%	-1.94%	83.66%
Enterprise Value	31,388	30,155	8,497	7,788	11,314	11,817
Last Close Price	402.00	397.00	136.58	113.24	170.33	180.59
PB Ratio	1.32	1.31	2.02	2.61	7.25	28.33
P/TBV Ratio	3.13	3.09	3.95	4.41	11.18	28.87
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.03	0.01
Net Debt / Equity Ratio	-0.65	-0.65	-0.97	-0.94	-0.92	-1.78
Net Debt / EBITDA Ratio	5.74	5.74	3.57	2.95	3.61	2.39
Net Debt / FCF Ratio	11.23	11.23	5.05	3.17	4.17	2.76
Quick Ratio	57.68	57.68	33.66	23.70	20.60	1.72
Current Ratio	58.18	58.18	34.45	24.69	20.94	1.74
Return on Equity (ROE)	-16.93%	-16.93%	-28.66%	-41.08%	-41.98%	-70.57%
Return on Assets (ROA)	-11.54%	-11.54%	-19.97%	-25.16%	-20.05%	-19.74%
Return on Capital Employed (ROCE)	-11.40%	-11.40%	-27.10%	-31.70%	-25.10%	-74.70%
Earnings Yield	-4.10%	-4.15%	-6.88%	-7.68%	-2.49%	-3.39%
FCF Yield	-4.36%	-4.41%	-9.48%	-11.34%	-3.05%	-2.27%
Buyback Yield / Dilution	-4.46%	-4.45%	-6.24%	-3.14%	-4.27%	-10.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.